
Stryker (SYK) Stock Forecast & Price Target
Stryker (SYK) Analyst Ratings
Bulls say
Stryker is facing slower adoption in the ASC setting compared to expected which could impact the growth potential of the company's orthopaedics business. However, with the company's strong competitive position and visibility into revenue growth through strategic M&A, Stryker has the potential for long-term growth. Potential risks include unsuccessful execution of M&A and end-market expansion, potential tariff and macroeconomic headwinds, and lower-than-expected sales and EPS due to decreased demand or increased COGS. Additionally, the company's MedSurg and Neurotechnology segment, which includes a significant portion of Stryker's capital exposed revenue, has shown growth potential with recent acquisitions and could continue to drive overall growth for the company. While the recent cyber incident impacted their 1Q26 results, management expects to recover lost sales and continue to benefit from healthy procedure growth and product launches. Overall, Stryker appears to be well-positioned in the med-tech industry with potential for above-average revenue and EPS growth.
Bears say
Stryker is forecasted to slow below market average organic revenue due to permanent haunt that SYK has a negative debt to muhiple and must depend on improvements from Ortho end markets amidst decreasing global market trend plus tough competition in robotics line that could drive downside risks against Street expectations overall moving forward.
This aggregate rating is based on analysts' research of Stryker and is not a guaranteed prediction by Public.com or investment advice.
Stryker (SYK) Analyst Forecast & Price Prediction
Start investing in Stryker (SYK)
Order type
Buy in
Order amount
Est. shares
0 shares